SpacDeskROIVANT SCIENCES LTD
Completed deSPAC · 1 SPAC · 1 closed · 0 announced
Montes Archimedes Acquisition Corp, trading under ticker MAAC, was a healthcare-focused special purpose acquisition company that completed its IPO in 2021 and announced a business combination with Roivant Sciences Ltd. in May of that year. Roivant Sciences is a biopharmaceutical holding company that develops and commercializes medicines across multiple therapeutic areas through a network of clinical-stage subsidiary companies, known as "Vants." Sponsored by Montes Archimedes Sponsor LLC, MAAC targeted the biotech and pharmaceutical sector. The transaction is now closed, with Roivant Sciences trading on Nasdaq under the ticker ROIV. Sign up for full data on SpacDesk to access complete deal analytics, filing history, and SPAC market coverage.
SPAC Counterparty (1)
| Symbol | Issuer | Status | Announced | Close | IPO Size | PIPE | Sponsor |
|---|---|---|---|---|---|---|---|
| MAAC | Montes Archimedes Acquisition Corp | Closed | 2021-05-03 | 2021-10-01 | $500.0M | $220.0M | Patient Square Capital |